Correction Volume 13, Issue 20 pp 23871
Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
- 1 Department of Pathology and Experimental Therapeutics, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
- 2 Biomedical Network Research Center on Neurodegenerative Diseases (CIBERNED), Institute Carlos III, L’Hospitalet de Llobregat, Barcelona, Spain
- 3 Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
- 4 Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain
- 5 Anesthesia and Critical Care Department, Bellvitge University Hospital ‐ University of Barcelona L’Hospitalet de Llobregat, Barcelona, Spain
- 6 Neuropathology, Pathologic Anatomy Service, Bellvitge University Hospital, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
- 7 Institute of Neurosciences, University of Barcelona, Barcelona, Spain
Received: October 25, 2021 Accepted: October 28, 2021 Published: October 31, 2021
https://doi.org/10.18632/aging.203667How to Cite
Correction for:
Aging (Albany NY). 2018;
10:2367-2382
.
https://doi.org/10.18632/aging.101551
PMID: 30215603
Copyright: © 2021 Andrés‐Benito et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been corrected: YKL40 values in text and figures represent ng/mL, not pg/mL This alteration does not affect the results or conclusions of this work.